Haris Khan•Content Strategist & Career Researcher•
Amgen is hiring an Associate Full Stack Engineer to support the design, development, and maintenance of high-quality software applications that address complex business needs. As part of the development team, you will work alongside senior engineers and cross-functional teams including product managers and designers. This role involves both front-end and back-end development responsibilities and requires a strong foundation in cloud technologies and modern software practices.
This role may require working in later hours and could include second or third shift schedules based on business needs. Candidates must be open to working evening or night shifts as required.
Amgen offers a collaborative, innovative, and science-driven environment with a strong focus on personal and professional growth. Along with a competitive base salary, you will receive comprehensive Total Rewards aligned with local standards. You will contribute to a mission that impacts millions of lives and have the opportunity to grow your career in a globally recognized biotechnology company.
Python, JavaScript, SQL, NoSQL, API Integration, Microservices, Serverless Architecture, Docker, Kubernetes, AWS, Azure, GCP, Prometheus, Grafana, Splunk, Hadoop, Spark
Amgen Inc. is one of the world’s largest independent biotechnology companies, founded in 1980 and headquartered in Thousand Oaks, California. Amgen’s mission is to serve patients by using science and innovation to dramatically improve people’s lives. The company focuses on discovering, developing, manufacturing, and delivering innovative human therapeutics, particularly in the areas of oncology, nephrology, cardiology, and inflammation.
With over 25,000 employees worldwide, Amgen is recognized for its robust pipeline and portfolio of biologic medicines, including well-known products such as Enbrel, Neulasta, and Repatha. The company is highly regarded for its commitment to scientific excellence and its leadership in biotechnology. In recent news, Amgen completed the acquisition of Horizon Therapeutics in 2023, significantly expanding its rare disease portfolio and reinforcing its position as a global biopharmaceutical leader.
Websiteamgen.com